Relationship of Semaphorin Proteins with Blood Markers in Patients with COVID-19
Journal of Turkish Clinical Biochemistry · 2023
DOI: 10.56615/tkbd.2023.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Turkish Clinical Biochemistry, 2023. Verfasst von Hamza Malik Okuyan und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
The COVID outbreak is a serious health problem affecting socio-economic life and healthcare systems worldwide. Although the role of Semaphorins in some diseases is relatively known, the association of these molecules with the pathogenesis of COVID-19 remains unclear. Therefore, we aimed to investigate the relationship of Semaphorins (Sema3A, Sema4A, Sema4D and Sema7A) with biochemical and inflammatory alterations and their roles in predicting the presence of disease and disease severity in COVID-19 patients. Material and Method: A total of 144 COVID-19 patients and 20 healthy individuals were enrolled in the current study. Serum Semaphorins were analyzed using Enzyme-linked Immunosorbent Assay. Other laboratory parameters were measured using routine laboratory techniques.
Results
Sema3A concentrations were elevated in both patients with severe and non-severe COVID-19 groups compared with healthy controls (p
Zitieren
APA
Okuyan, H. M., Doğan, S., Bal, T., & Çabalak, M. (2023). Relationship of Semaphorin Proteins with Blood Markers in Patients with COVID-19. Journal of Turkish Clinical Biochemistry. https://doi.org/10.56615/tkbd.2023.10
Vancouver
Okuyan HM, Doğan S, Bal T, Çabalak M. Relationship of Semaphorin Proteins with Blood Markers in Patients with COVID-19. Journal of Turkish Clinical Biochemistry. 2023. doi:10.56615/tkbd.2023.10
BibTeX
@article{Okuyan2023,
author = {Okuyan, Hamza Malik and Doğan, Serdar and Bal, Tayibe and Çabalak, Mehmet},
title = {Relationship of Semaphorin Proteins with Blood Markers in Patients with COVID-19},
journal = {Journal of Turkish Clinical Biochemistry},
year = {2023},
doi = {10.56615/tkbd.2023.10}
}
EUVIMED